I 

117TH CONGRESS 

1ST SESSION H. R. 1303 

To amend the Controlled Substances Act to prohibit the knowing possession 

of a pill press mold with intent to manufacture in violation of such 

Act a counterfeit substance in schedule I or II in a capsule, tablet, 

and other form intended for distribution, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 24, 2021 

Mr. KUSTOFF (for himself and Ms. SPANBERGER) introduced the following 

bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of 

such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Controlled Substances Act to prohibit the 

knowing possession of a pill press mold with intent to 

manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and 

other form intended for distribution, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Criminalizing Abused 

5 Substance Templates Act of 2021’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 1303 IH

1 SEC. 2. UNLAWFUL POSSESSION OF PILL PRESS MOLDS. 

2 (a) PROHIBITION.—Section 401 of the Controlled 

3 Substances Act (21 U.S.C. 841) is amended by adding at 

4 the end the following: 

5 ‘‘(i) OFFENSE REGARDING UNLAWFUL POSSESSION

6 OF PILL PRESS MOLDS.— 

7 ‘‘(1) IN GENERAL.—Whoever, with intent to 

8 manufacture in violation of this title a counterfeit 

9 substance in schedule I or II in a capsule, tablet, or 

10 other form for distribution, knowingly possesses a 

11 pill press mold, shall be imprisoned not more than 

12 20 years and fined in accordance with title 18, 

13 United States Code. 

14 ‘‘(2) DEFINITIONS.—In this subsection, the 

15 term ‘pill press mold’ means any punch, die, plate, 

16 stone, or other object designed to print, imprint, or 

17 reproduce on a controlled substance (or the con18 tainer or labeling thereof) the trademark, trade 

19 name, or other identifying mark, imprint, number, 

20 or device, or any likeness thereof, of a manufacturer, 

21 distributor, or dispenser other than the person or 

22 persons who in fact manufactured, created, distrib23 uted, or dispensed such product, thereby rendering 

24 it a counterfeit substance.’’. 

25 (b) SENTENCING GUIDELINES.—Pursuant to its au26 thority under section 994 of title 28, United States Code, 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 1303 IH

1 and in accordance with this section, the United States 

2 Sentencing Commission shall review and amend, as appro3 priate, the Federal sentencing guidelines and policy state4 ments to ensure that the guidelines provide for a penalty 

5 enhancement of not less than 2 offense levels above the 

6 offense level otherwise applicable for a violation of section 

7 401(a) of the Controlled Substances Act (21 U.S.C. 

8 841(a)) if the defendant is found, in connection with such 

9 violation of section 401(a), to be in violation of section 

10 401(i) of the Controlled Substances Act, as added by sub11 section (a). 

Æ 


kjohnson on DSK79L0C42PROD with BILLS